Mark Bachleda Galera Therapeutics, Inc. (GRTX) insider trading activity
Mark Bachleda is Chief Commercial Officer of Galera Therapeutics, Inc.. Currently has a direct ownership of 11,000 shares of GRTX, which is worth approximately $550. The most recent transaction as insider was on Mar 16, 2023, when has been sold 11,000 shares (Common Stock) at a price of $2.25 per share, resulting in proceeds of $24,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
11K
0%
3M change
0%
12M change
Total Value Held
$550
MB
Mark Bachleda
Chief Commercial Officer
Malvern, PA